These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 7872708

  • 1. Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines.
    Bando T, Kasahara K, Shibata K, Nakatsumi Y, Fujimura M, Matsuda T.
    Anticancer Res; 1994; 14(6B):2727-30. PubMed ID: 7872708
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
    Bando T, Fujimura M, Kasahara K, Matsuda T.
    Anticancer Res; 1998; 18(2A):1085-9. PubMed ID: 9615770
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.
    Koenuma M, Kasai H, Uchida N, Wada T, Hattori M, Oguma T, Totani T, Inaba M.
    Anticancer Res; 1995; 15(2):417-21. PubMed ID: 7763015
    [Abstract] [Full Text] [Related]

  • 8. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
    Tsai CM, Hsiao SH, Frey CM, Chang KT, Perng RP, Gazdar AF, Kramer BS.
    Cancer Res; 1993 Mar 01; 53(5):1079-84. PubMed ID: 8382553
    [Abstract] [Full Text] [Related]

  • 9. EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
    Donato NJ, Perez M, Kang H, Siddik ZH, Ling YH, Perez-Soler R.
    Clin Cancer Res; 2000 Jan 01; 6(1):193-202. PubMed ID: 10656450
    [Abstract] [Full Text] [Related]

  • 10. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G, Kusumoto T, Korbut TT, Cullere-Luengo F, Teicher BA.
    Cancer Res; 1994 Mar 15; 54(6):1497-502. PubMed ID: 8137254
    [Abstract] [Full Text] [Related]

  • 11. Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells.
    Futagami M, Sato S, Sakamoto T, Yokoyama Y, Saito Y.
    Gynecol Oncol; 2001 Sep 15; 82(3):544-9. PubMed ID: 11520153
    [Abstract] [Full Text] [Related]

  • 12. Establishment and biochemical properties of cis-diamminedichloroplatinum(II)-resistant A549 lung cancer cells.
    Yamauchi N, Shiotani T, Yamaji Y, Fujita J, Hata Y, Irino S.
    Cancer Biochem Biophys; 1991 Nov 15; 12(3):177-83. PubMed ID: 1844910
    [Abstract] [Full Text] [Related]

  • 13. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L, Osmak M, Jaksić M.
    Neoplasma; 1994 Nov 15; 41(3):163-9. PubMed ID: 7935985
    [Abstract] [Full Text] [Related]

  • 14. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC, Prins J, Meijer C, Uges DR, De Vries EG, Mulder NH.
    Anticancer Res; 1996 Nov 15; 16(4A):1963-70. PubMed ID: 8712728
    [Abstract] [Full Text] [Related]

  • 15. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T, Saijo N.
    Jpn J Cancer Res; 1993 Jan 15; 84(1):83-92. PubMed ID: 8383649
    [Abstract] [Full Text] [Related]

  • 16. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 15; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A, Weixel K, Saijo N.
    Cell Growth Differ; 1996 Nov 15; 7(11):1507-12. PubMed ID: 8930400
    [Abstract] [Full Text] [Related]

  • 18. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.
    Lee YC, Saijo N, Sasaki Y, Takahashi H, Sakurai M, Ishihara J, Hoshi A, Chen KM, Hamburger AW.
    Jpn J Clin Oncol; 1985 Dec 15; 15(4):637-44. PubMed ID: 4094096
    [Abstract] [Full Text] [Related]

  • 19. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
    Fujimori S, Abe Y, Nishi M, Hamamoto A, Inoue Y, Ohnishi Y, Nishime C, Matsumoto H, Yamazaki H, Kijima H, Ueyama Y, Inoue H, Nakamura M.
    Int J Oncol; 2004 Aug 15; 25(2):413-8. PubMed ID: 15254739
    [Abstract] [Full Text] [Related]

  • 20. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1993 Aug 15; 13(6A):2261-5. PubMed ID: 8297143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.